Trial Profile
Objective Assessment of Metabolic Monitoring in Patients Treated With Seroquel or Seroquel XR/Quetiapine Fumarate: Use of IMS Disease Analyzer to Assess Physician Behaviour in the UK and Germany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2014
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders; Major depressive disorder; Schizophrenia
- Focus Adverse reactions
- Sponsors AstraZeneca
- 27 Jan 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 22 Feb 2013 New trial record